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Purpose: To assess the clinical reliability of the Bosniak IIF category and to determine 
the proper radiologic follow-up duration and intervals for category IIF complex renal 
cysts.
Materials and Methods: We studied 201 patients with category IIF renal cysts from 
January 1996 to January 2011. Renal cyst progression to category III was defined as 
an increase in complexity of the cyst in follow-up radiologic studies. We monitored radio-
logic changes and progression of renal cysts during the follow-up period and analyzed 
the pathologic results of those patients who were treated surgically. 
Results: At a mean follow-up of 20 months, only 14 cases (7%) showed evidence of pro-
gression to stage III, with a mean time to progression of 11 months (range, 3 to 65 
months). There were no significant differences in age, gender, cyst size, or change in 
cyst size between the progressive and non-progressive groups. Of 12 cases treated surgi-
cally, 10 cases (83.3%) showed renal cell carcinoma with pT1 stage, and there was no 
recurrence during postoperative follow-up of 23 months. Of the 187 patients without 
radiologic progression, 23 cases were treated surgically, and all of them showed benign 
cysts.
Conclusions: The IIF category showed significant clinical reliability by a low rate of 
radiologic progression and a high rate of malignancy in the radiologic progressive group 
but a low rate of malignancy in the non-progressive group. Although it is hard to decide 
on a proper follow-up duration because of the variable time to progression, too frequent 
follow-up study seems to be unnecessary considering that most malignant cases were 
of a low stage. 
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INTRODUCTION 
Renal cysts are common lesions. More than 50% of the pop-
ulation aged 50 years and older has renal cysts [1], and most 
simple renal cysts do not require further evaluation or in-
tervention because they are harmless [2]. Due to advances 
in and the widespread use of abdominal ultrasonography, 
abdominal computed tomography (CT), and magnetic reso-
nance imaging (MRI) as diagnostic tools [3], the incidence 
of complex renal cysts and cystic renal cell carcinoma has 
increased in recent years. Advanced imaging studies have 
brought early diagnosis and early treatment as a result. 
However, they have also brought unnecessary surgeries 
and post-operative complications for benign renal cysts. 
Therefore, it is very important to differentiate cystic renal 
cell carcinoma from benign renal cysts during the pre-
operative work-up [3]. Abdominal CT or MRI studies are 
used to differentiate between simple renal cysts and cystic 
renal malignancies. However, it is still a major challenge 
to recognize the differences between them.
Bosniak suggested a classification system for complex 
renal cysts in 1986 [4], and his classification system is the 
one most widely used to evaluate renal cysts [2]. Cysts are 
classified into four different levels for patient manage-
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ment: simple renal cysts (category I), benign renal cysts 
with complications but not in need of surgery (category II), 
potentially malignant renal cysts in need of surgery 
(category III), and cystic renal cell carcinomas (category 
IV) [3]. However, the controversy and difficulty lies in those 
complex cystic renal masses that lie between Bosniak II 
and III [2,5]. To address this problem and based on the clin-
ical experience of Bosniak, the IIF categorization was first 
suggested in 1993 for lesions that are more complex than 
a category II cyst but are still thought to be benign and re-
quire only serial imaging to confirm stability [6,7]. 
Presently, there is a consensus that radiologic surveil-
lance with intervention upon increasing complexity is a 
safe and effective protocol for managing category IIF le-
sions [8], but the proper radiologic follow-up duration and 
intervals for these lesions remain unproven. Some reports 
of the clinical outcomes of category IIF complex renal cysts 
in Western countries have been published [8], but no re-
ports in Korea have been published. Therefore, we retro-
spectively evaluated the pathological and clinical out-
comes of category IIF complex renal cysts to assess the clin-
ical reliability of the IIF category and to determine the 
proper radiologic follow-up duration and intervals for 
these lesions.
MATERIALS AND METHODS
After institutional review board approval was received, 
from January 1996 to January 2011, patients were identi-
fied retrospectively from a urology billing database by us-
ing diagnostic codes for renal cysts, renal masses, and renal 
neoplasms as well as from a preexisting radiology database 
by using the key words Bosniak and cyst. A total of 5,946 
patients were diagnosed with cystic renal disease. Among 
them, 278 patients were diagnosed with category IIF cysts 
by CT imaging. Seventy-seven were not included in the 
study owing to a lack of radiologic follow-up, leaving 201 
patients for the final analysis. 
Diagnosis of all the patients was done by using a kidney 
spiral CT protocol or an abdominal-pelvic contrast CT 
protocol. The CT examinations that took place at our in-
stitution were performed by using a 4-channel LightSpeed 
QX/I MDCT scanner (GE Medical Systems, Milwaukee, 
WI, USA) or a 16-channel Sensation 16 MDCT scanner 
(Siemens Medical System, Erlangen, Germany). In the ab-
dominal pelvic contrast CT protocol, after unenhanced im-
ages were acquired, arterial phase and delayed phase scan-
ning were performed. In the kidney spiral CT protocol, un-
enhanced images were acquired first after the patients in-
gested E-Z-CAT oral contrast agent (2% barium sulfate 
suspension) 30 minutes before the examination. Then, cor-
ticomedullary images were acquired 30 seconds after bolus 
injection of Ultravist 300 (iopromide) or Lopamiro 300 
(iopamidol) (Braco, Milano, Italy) intravenous contrast 
material into the antecubital vein with the aorta, renal ar-
tery, and renal cortex highlighted. The section thickness 
was 2.5 to 5.0 mm and the total amount of contrast material 
was a maximum of 160 ml at a rate of 3 ml/s. Early excretory 
phase scans were obtained approximately 120 to 150 sec-
onds after contrast injection when the vena cava and the 
renal vein were highlighted and the renal pelvis began con-
trast pooling. 
Category IIF lesions were defined as those being more 
complex than a category II cyst but still thought to be be-
nign and to require only serial imaging to confirm stability 
[6,7]. They could contain an increased number of septa or 
have minimal thickening of the wall or septa, and whether 
there was measurable enhancement of these structures 
was often uncertain [9]. All category IIF lesions were diag-
nosed by a single uroradiologist.
Upon chart review, follow-up radiologic and pathologic 
data were recorded. The radiologic data were surveyed for 
date of radiologic study, change in lesion size, and interval 
change in complexity. Cyst progression was defined as an 
increase in cyst complexity diagnosed by the radiologist, 
but an increase in cyst size was not considered progression. 
Differences between the radiologic progressive group 
and non-progressive group were compared. Patients re-
ceived surgical treatment due to progression into category 
III, and this group included those who did not have pro-
gression but underwent surgery on their own account. 
Their pathological outcomes were recorded, including be-
nign or malignant histology, histological subtype, and 
pathological stage. Marsupialization was included in the 
procedure for those in the non-progressive group who un-
derwent surgery. Fluid cytology and cyst wall were tested 
by marsupialization to determine whether the cysts were 
benign or malignant. 
To analyze the differences between the radiologic pro-
gressive group and the non-progressive group, Student’s 
t-test was used for continuous variables, and chi-square 
test was used for categorical variables. A p-value less than 
0.05 was considered statistically significant. Data were an-
alyzed by using SPSS ver. 12 (SPSS Inc., Chicago, IL, USA). 
RESULTS
The clinical characteristics of all patients are shown in 
Table 1. During the mean follow-up period of 20 months 
(range, 1 to 141 months; median, 12 months), 154 cysts 
(77%) showed no changes in size, 35 (17%) increased in size, 
and 12 (6%) decreased in size. Fourteen cases (7%) showed 
renal cyst progression and the mean time to progression 
was 11 months (range, 3 to 65 months; median, 6 months). 
There were no significant differences between the pro-
gressive group and the non-progressive group with regard 
to age (p=0.948), gender (p=0.292), size of cyst (p=0.534), 
or change in size during follow-up (p=0.494) (Table 2). 
Among 14 patients with radiologic progression, 2 of 14 
cases refused surgery; the remaining 12 cases were treated 
surgically. Ten cases (83.3%) were found to be malignant 
(Fig. 1). Of these malignant cases, six were T1a and four 
were T1b. Six of the tumors had clear cell histology, three 
had a papillary histology, and one had chromophobe histol-
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TABLE 1. Patients’ characteristics 
       Characteristic Value
No. of patients 201
Age (yr), mean (SD)   60.1 (14.6)
Sex  (Male:female) 133:68
Size (cm), mean (SD)   3.4 (2.4)
Follow-up (mo)     20 (range, 1-141; median, 12)
Time to progression (mo) 11 (range, 3-65; median, 6)
No. of cysts that progressed, n (%) 14 (7)
Size change, n (%)
    No change:increase:decrease 154 (77):35 (17):12 (6)
TABLE 2. Comparison of variables between progressive and 
non-progressive groups with bosniak category IIF cysts
Non-pro-
Progression
     Parameter gression p-value
(n=14)
(n=187)
Age (yr), mean (SD) 60.4 (14.4) 60.1 (14.7) 0.948
Sex (Male:female) 11:3 122:65 0.292
Size (cm), mean (SD) 3.2 (1.3) 3.5 (2.5) 0.534
Size change, n (%) 0.494
    No change   9 (64) 145 (78)
    Increase   4 (29)   31 (16)
    Decrease 1 (7) 11 (6)
FIG. 1. A 69-year-old man with a category IIF cystic lesion in the right kidney. (A) Initial contrast-enhanced transverse computed 
tomography scan depicts a 2.8-cm cystic mass that contains multiple minimally smooth thickening of septa. (B) On follow-up 9 
months later, the cystic renal mass contains grossly thickened and irregular septa in which there is measurable enhancement (white 
arrow). On the basis of these findings, the lesion was reclassified as a category III cyst. (C) The patient underwent radical 
nephrectomy and the lesion was found to be a pT1 stage conventional renal cell carcinoma with focal hemorrhage (H&E, ×400).
TABLE 3. Pathologic outcome of surgically treated progressive 
groups
Variable Value
No. of patients 12
No. of malignant tumors, n (%) 10 (83.3)
Pathologic T stage
    T1a:T1b 6:4
Histologic type
    Clear cell:chromophobe:papillary 6:1:3
ogy (Table 3). A representative case with radiologic pro-
gression is described in Fig. 1. All of the 10 patients with 
malignancy were found with no post-operative recurrence 
for an average of 23 months (range, 3 to 48 months; median, 
18 months). 
Of the 187 patients without radiologic progression, 23 
cases were treated surgically. Two patients had lesions 
that increased only in size (1.4 to 1.8 cm and 13.7 to 14.8 
cm) and underwent surgery on their own account. Three 
patients underwent a nephrectomy while being treated 
surgically for other disease. The remaining 18 cases were 
treated surgically owing to the patient’s request: 13 cases 
by nephrectomy and 10 by renal cyst marsupialization. All 
23 patients who underwent surgery were reported to have 
benign cysts. No post-operative malignant changes were 
observed for an average of 30 months (range, 1 to 84 
months; median, 32 months).
DISCUSSION
The Bosniak classification system is used to diagnose and 
manage complex renal cysts. If the category IIF desig-
nation of the Bosniak classification system is accurate, it 
can be used to predict minimal progression in category IIF 
lesions and a low malignancy rate [8]. In our study, during 
the mean follow-up period of 20 months, 14 cases (7%) 
showed renal cyst progression. The mean time to pro-
gression was 11 months (range, 3 to 65 months; median, 
6 months). This is slightly lower than the 14.8% pro-
gression rate in an evaluation of radiologic follow-up of 81 
category IIF lesions with a median follow-up of 15 months 
[8]. Also, 23 cases without progression were treated surgi-
cally in our study and all of them were reported as benign 
cysts. The malignancy rate in surgically treated category 
IIF lesions is historically 0 to 25%, but the previous studies 
reporting these values were done in very small populations 
[10,11]. This supports the clinical reliability of the Bosniak 
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IIF category. The malignancy rate in surgically treated cat-
egory III lesions is historically 25 to 100% [8]. If all histor-
ically reported category III lesions with a pathologically 
proven diagnosis are summed, there is an overall 51% ma-
lignancy rate [12]. In our study, 12 of 14 cases of progression 
were treated surgically except for the two cases who re-
fused surgery; 10 (83.3%) of these 12 cysts were found to 
be malignant. The malignancy rate in this study was high-
er than the historically reported malignancy rate. This fur-
ther supports the clinical reliability of the Bosniak IIF 
category.
No clear guidelines concerning the proper radiologic fol-
low-up duration and intervals have been proposed, but if 
increasing complexity is found by continuous radiologic 
studies, exploratory surgery is recommend to rule out ma-
lignancy [8]. Most category IIF patients are not surgically 
treated; therefore, additional follow-up studies are needed 
to confirm that the cysts in these patients remain stable 
and benign. In our study, the average time to progression 
was 11 months (range, 3 to 65 months; median, 6 months). 
The longest progression time of 65 months (5.4 years) in-
dicates that follow-up studies should be performed for at 
least 5 years. This is because renal cysts show a slow growth 
pattern [9].
It can be argued that category IIF cysts should be surgi-
cally removed, for example, in young patients who do not 
want more follow-up studies [9]. However, surgery is not 
necessary for all patients; in our study, all 23 patients who 
underwent surgery had benign cysts. Most cases of malig-
nancy in surgically treated progressive groups are 
low-stage renal cell carcinoma. The prognosis of these car-
cinomas is satisfactory compared with other renal malig-
nancies owing to the low metastatic rate [13-16]. Therefore, 
delayed diagnosis of several malignancies did not have se-
vere consequences or adversely affect patients’ outcome. 
Thus, for elderly patients in poor physical condition, fol-
low-up study is recommended rather than surgery. For 
young patients, too frequent follow-up study would be 
unnecessary.
This study had a few limitations. Because our study was 
retrospective and the cases were collected over 10 years, 
the radiologic studies were performed on a variety of helical 
and conventional CT scanners. In addition, the type and 
amount of intravenous contrast material also varied. 
Second, intervention was influenced by clinical parame-
ters such as patient age and physical condition. Although 
the Bosniak classification system is based on imaging find-
ings, it can add variability to managing cases by affecting 
clinical parameters. Lastly, the sample size was small be-
cause some patients moved away or transferred to another 
hospital, resulting in follow-up loss. Additional patients 
and a prolonged follow-up period are needed in future 
studies.
CONCLUSIONS
We could confirm the clinical reliability of the IIF category 
on the basis of the fact that the category IIF patients 
showed a low radiologic progression rate (7%), and those 
patients who progressed to category III had a high malig-
nancy rate (83.3%), whereas a low rate (0%) of malignancy 
was found in the non-progressive group. Although it is hard 
to decide on a proper follow-up duration because of the vari-
able time to progression, too frequent follow-up study 
would be unnecessary considering that most malignant 
cases were of a low stage. Nevertheless, our study has the 
advantage of a large cohort in which all cases were collected 
from a single institution. To our knowledge, this study is 
the first study to evaluate the pathological and clinical out-
comes of category IIF complex renal cysts in Korean 
patients.
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